Programs
Continuing Medical Education (CME) Programs
Upcoming programs
No upcoming programs are scheduled at this time. Check back soon.
CME Programs on Asthma and Allergy
View our programs on asthma and allergy below. You can earn an AMA PRA Category 1 Credit™, as noted.
Applying the Latest Guidelines and Recommendations to Initiate Biologic Therapy and Control Moderate-to-Severe Asthma Symptoms
Topics discussed during this course include:
- The burden of uncontrolled asthma
- The impact of asthma phenotypes/endotypes and type 2 comorbidities
- Current data on the efficacy and safety of biologics
Earn AMA PRA Category 1 Credit™ through Nov. 29, 2023. Watch on demand.
Biologic Therapy for Patients with Severe Asthma: Impeding the Inflammatory Cascade
- Roles of various inflammatory pathways in severe asthma
- Mechanisms of action of various therapies and their safety and efficacy data
- How a new treatment option targeting TSLP can be integrated into asthma management plan
Earn AMA PRA Category 1 Credit™ through Aug. 23, 2023. Watch on demand.
TARGETING ASTHMA: Community-based Strategies to Enhance Care Access for Children, Adolescents, and Adults – Focus on Social Determinants of Health and Inequities of Care
- How to identify patients with moderate-to-severe asthma who may benefit from targeted biologic agents
- How to identify the place of type-2-targeted biologics in the management of moderate-to-severe asthma
Earn AMA PRA Category 1 Credit™ through April 5, 2023. Watch on demand.
CME Programs on Allergic Conditions
View our programs on allergic conditions such as chronic spontaneous urticaria (CSU), eosinophilic esophagitis (EoE), atopic dermatitis (AD), and more. You can earn an AMA PRA Category 1 Credit™, as noted.
Chronic Spontaneous Urticaria: New Hope with Emerging Targeted Agents
- The latest in chronic spontaneous urticaria (CSU) treatment options
- Management and treatment escalation standards
- Perspectives from the patient journey
Please note the AMA PRA Category 1 Credit™ is no longer available.
Disparity and Equity in Moderate-to-Severe AD Care: Enhancing Access to Multidisciplinary Care for Patients from Diverse Populations
- The impacts that age, race, and ethnicity have on atopic dermatitis (AD)
- Management of moderate-to-severe atopic dermatitis
- Strategies to increase access to care for all
Earn AMA PRA Category 1 Credit™ through Oct. 24, 2023. Watch on demand.
Eosinophilic Esophagitis: Guidelines and Emerging Evidence for Effective Management Strategies
- How to recognize the symptoms of eosinophilic esophagitis (EoE) across a variety of patient ages to facilitate an early diagnosis
- Emerging data on new, more efficient, targeted agents for the management of EoE
Earn AMA PRA Category 1 Credit™ through March 8, 2023. Watch on demand.
Moving Toward a Targeted Approach for Nasal Polyps
Topics discussed during this course include:
- The patient burden of nasal polyps
- Limitations of traditional nasal polyp treatments and emerging therapies for those with nasal polyps
- Rationale for targeted approaches to nasal polyp management
Please note the AMA PRA Category 1 Credit™ is no longer available.
Multidisciplinary Approach to the Management of CRS with Refractory Nasal Polyps: ENT, Allergist, and Patient Partnerships to Enhance Care and QoL
- Patient-centered treatment options for chronic rhinosinusitis with nasal polyps (CRSwNP)
- Disease burden
- The impacts that biologics and surgery have on symptoms and quality of life (QoL)
Earn AMA PRA Category 1 Credit™ through Oct. 21, 2023. Watch on demand.
